UNSPSC 51172177: Oxyphencyclimine hydrochloride

This classification denotes an antispasmotic agent and antimuscarinic agent with the molecular formula C20H28N2O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GWO1432WOU, chemically known as 1,4,5,6-tetrahydro-1-methyl-2-pyrimidinylmethyl alpha-cyclohexyl-alpha-phenylglycolat but more generally known as oxyphencyclimine hydrochloride, which bears US NIH Compound Identifier 4642.

UNSPSC 51172177 Oxyphencyclimine hydrochloride is a Commodity code that, based on recent state and local solicitation activity, frames drug testing and specimen collection services rather than the pharmaceutical ingredient itself. State and local purchasing under this code encompasses offender drug screening and confirmation testing, including immunoassay panels, mass spectrometry confirmation (LC/MS/MS or GC/MS), alternative matrices (oral fluid, hair), and associated collection-site staffing and laboratory services. Issuing bodies include county community supervision and corrections departments. Lab certification requirements (SAMHSA, state DPS, or CAP) are standard across opportunities. Pricing is typically structured on a per-test basis with multiple service tiers—screening only, confirmation after screening, and screening with automatic confirmation of positives—and contracts generally span two to five years with optional renewal periods.

Collin County, Texas, represents the primary recent activity under this code. The county's Community Supervision and Corrections Department issued RFP 2026-327 on September 25, 2026, for offender specimen collection and drug testing services with a response deadline of July 23, 2026, at 2:00 p.m., an estimated contract value of $600,000, and an anticipated award date of August 10, 2026. The scope calls for staffing two collection sites in Plano and McKinney with approximately 25,031 annual tests across five-panel and six-panel screens, operation of an Interactive Voice Response system for randomized testing notifications, electronic reporting, and adherence to price-protection and cost-control provisions tied to medical Consumer Price Index benchmarks capped at 3.0 percent annually. Collin County reserves the right to award the RFP in whole or in part to multiple vendors.